{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:25:35Z","timestamp":1789575935906,"version":"build-2803163510"},"reference-count":22,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2015]]},"DOI":"10.5582\/irdr.2015.01002","type":"journal-article","created":{"date-parts":[[2015,3,31]],"date-time":"2015-03-31T16:36:49Z","timestamp":1427819809000},"page":"76-81","source":"Crossref","is-referenced-by-count":65,"title":["A systematic review of hereditary spherocytosis reported in Chinese biomedical journals from 1978 to 2013 and estimation of the prevalence of the disease using a disease model"],"prefix":"10.5582","volume":"4","author":[{"given":"Chao","family":"Wang","sequence":"first","affiliation":[{"name":"School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Science"},{"name":"Key Laboratory for Biotech Drugs of the Ministry of Health, Key Laboratory for Rare Disease of Shandong Province, Shandong Medicinal Biotechnology Center, Shandong Academy of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhou","family":"Cui","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biotech Drugs of the Ministry of Health, Key Laboratory for Rare Disease of Shandong Province, Shandong Medicinal Biotechnology Center, Shandong Academy of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Science"},{"name":"Key Laboratory for Biotech Drugs of the Ministry of Health, Key Laboratory for Rare Disease of Shandong Province, Shandong Medicinal Biotechnology Center, Shandong Academy of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Science"},{"name":"Key Laboratory for Biotech Drugs of the Ministry of Health, Key Laboratory for Rare Disease of Shandong Province, Shandong Medicinal Biotechnology Center, Shandong Academy of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiang","family":"Han","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biotech Drugs of the Ministry of Health, Key Laboratory for Rare Disease of Shandong Province, Shandong Medicinal Biotechnology Center, Shandong Academy of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet. 2008; 372:1411-1426.","DOI":"10.1016\/S0140-6736(08)61588-3"},{"key":"2","unstructured":"2. Shah A. Hemoglobinopathies and other congenital hemolytic anemia. Indian J Med Sci. 2004; 58:490-493."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bolton-Maggs PH, Langer JC, Iolascon A, Tittensor P, King MJ; General Haematology Task Force of the British Committee for Standards in Haematology. Guidelines for the diagnosis and management of hereditary spherocytosis--2011 update. Br J Haematol. 2012; 156:37-49.","DOI":"10.1111\/j.1365-2141.2011.08921.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bogus\u0142awska DM, Heger E, Chorzalska A, Nierzwicka M, Ho\u0142ojda J, Swiderska A, Straburzy\u0144ska A, Pa\u017adzior G, Langner M, Sikorski AF. Hereditary spherocytosis: Identification of several HS families with ankyrin and band 3 deficiency in a population of southwestern Poland. Ann Hematol. 2004; 83:28-33.","DOI":"10.1007\/s00277-003-0739-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Godal HC, Heist\u00f8 H. High prevalence of increased osmotic fragility of red blood cells among Norwegian blood donors. Scand J Haematol. 1981; 27:30-34.","DOI":"10.1111\/j.1600-0609.1981.tb00448.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Jensson O, J\u00f3nasson JL, Magn\u00fasson S. Studies on hereditary spherocytosis in Iceland. Acta Med Scand. 1977; 201:187-195.","DOI":"10.1111\/j.0954-6820.1977.tb15680.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Eber SW, Pekrun A, Neufeldt A, Schr\u00f6ter W. Prevalence of increased osmotic fragility of erythrocytes in German blood donors: Screening using a modified glycerol lysis test. Ann Hematol. 1992; 64:88-92.","DOI":"10.1007\/BF01715351"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Premetis E, Stamoulakatou A, Loukopoulos D. Erythropoiesis: Hereditary spherocytosis in Greece: Collective data on a large number of patients. Hematology. 1999; 4:361-366.","DOI":"10.1080\/10245332.1999.11746460"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. S\u00e1nchez-L\u00f3pez JY, Camacho AL, Maga\u00f1a MT, Ibarra B, Perea FJ. Red cell membrane protein deficiencies in Mexican patients with hereditary spherocytosis. Blood Cells Mol Dis. 2003; 31:357-359.","DOI":"10.1016\/S1079-9796(03)00207-9"},{"key":"10","unstructured":"10. Ricard MP, Gilsanz F, Millan I. Erythroid membrane protein defects in hereditary spherocytosis. A study of 62 Spanish cases. Haematologica. 2000; 85:994-995."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cui Y, Zhao H, Liu Z, Liu C, Luan J, Zhou X, Han J. A systematic review of genetic skeletal disorders reported in Chinese biomedical journals between 1978 and 2012. Orphanet J Rare Dis. 2012; 7:55.","DOI":"10.1186\/1750-1172-7-55"},{"key":"12","unstructured":"12. Kruijshaar ME, Barendregt JJ, Hoeymans N. The use of models in the estimation of disease epidemiology. Bull World Health Organ. 2002; 80:622-628."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Friede A, Reid JA, Ory HW. CDC WONDER: A comprehensive on-line public health information system of the Centers for Disease Control and Prevention. Am J Public Health. 1993; 83:1289-1294.","DOI":"10.2105\/AJPH.83.9.1289"},{"key":"14","unstructured":"14. Chinese Center for Disease Control and Prevention. The national disease detection systems death surveillance data set (Yu Wang, Fu Gao, eds.). People&apos;s Medical Publishing House, BJ, China, 2011."},{"key":"15","unstructured":"15. National Bureau of Statistics of the People&apos;s Republic of China (2010). <i>http:\/\/www.stats.gov.cn\/tjsj\/pcsj\/rkpc\/6rp\/indexch.htm<\/i> (accessed February 1, 2015). (in Chinese)"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Abdullah F, Zhang Y, Camp M, Rossberg MI, Bathurst MA, Colombani PM, Casella JF, Nabaweesi R, Chang DC. Splenectomy in Hereditary Spherocytosis: Review of 1,657 Patients and Application of the Pediatric Quality Indicators. Pediatr Blood Cancer. 2009; 52:834-837.","DOI":"10.1002\/pbc.21954"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Bader-Meunier B, Gauthier F, Archambaud F, Cynober T, Mi\u00e9lot F, Dommergues JP, Warszawski J, Mohandas N, Tchernia G. Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis. Blood. 2001; 97:399-403.","DOI":"10.1182\/blood.V97.2.399"},{"key":"18","unstructured":"18. ORPHANET. Prevalence of rare diseases: Bibliographic data. <i>http:\/\/www.orpha.net\/orphacom\/cahiers\/docs\/GB\/Prevalence_of_rare_diseases_by_alphabetical_list<\/i>(accessed February 1, 2015). (in Chinese)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Villaverde-Hueso A, de la Paz MP, Mart\u00edn-Arribas MC, S\u00e1nchez-Valle E, Ram\u00edrez-Gonz\u00e1lez A, Biairdi P. Prevalence of scleroderma in Spain: An approach for estimating rare disease prevalence using a disease model. Pharmacoepidemiol Drug Saf. 2008; 17:1100-1107.","DOI":"10.1002\/pds.1660"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kruijshaar ME, Barendregt JJ, Van De Poll-Franse LV. Estimating the prevalence of breast cancer using a disease model: Data problems and trends. Popul Health Metr. 2003; 1:5.","DOI":"10.1186\/1478-7954-1-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27:1047-1053.","DOI":"10.2337\/diacare.27.5.1047"},{"key":"22","unstructured":"22. Murray CJ, Lopez AD. Quantifying disability: Data, methods and results. Bull World Health Organ. 1994; 72:481-494."}],"container-title":["Intractable &amp; Rare Diseases Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T08:19:33Z","timestamp":1498205973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/4\/2\/4_2015.01002\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2015.01002","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"value":"2186-361X","type":"electronic"},{"value":"2186-3644","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}